2025. Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 5-year Analysis of the KEEPsAKE 1 and 2 Trials. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s691. DOI:https://doi.org/10.25251/pwq1v445.